Percutaneous Nephrolithotomy Versus Extracorporeal Shock Wave Lithotripsy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00873054|
Recruitment Status : Completed
First Posted : April 1, 2009
Last Update Posted : February 3, 2014
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||32 participants|
|Official Title:||Percutaneous Nephrolithotomy Versus Extracorporeal Shock Wave Lithotripsy|
|Study Start Date :||October 2008|
|Actual Primary Completion Date :||October 2010|
|Actual Study Completion Date :||January 2011|
In this procedure,scope will be placed inside bladder and a plastic tube (stent) will be left to drain the kidney on the affected side in a routine manner. Next the patient will be transferred to a separate room and sound waves will be aimed at the center of the stone until the stone is broken into pieces.
In this procedure,scope will be placed inside bladder and a plastic tube (stent) will be left to drain the kidney on the affected side in a routine manner. Next, a small (1cm) cut will be made in the back and a tube will be placed into the kidney. Through this tube a small camera will be placed inside the kidney and break the stone into many pieces and remove them through the same tube. All fragments that can be seen will be removed. A different plastic tube (drain) will be placed through the cut and into the kidney and left in place for 5-7 days.
- The primary objective of this study is to compare the stone-free status after Extracorporeal Shock Wave Lithotripsy (ESWL) and Percutaneous Nephrolithotomy (PCNL) for kidney stones 10-20 mm in size. [ Time Frame: Within 3 months of enrollment ]
- A secondary objective is to assess the morbidity associated with use of the procedures i.e. any minor or major complications within 3 months of initial treatment. [ Time Frame: Within 3 months of enrollment ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00873054
|United States, West Virginia|
|Urology Center of Charleston|
|Charleston, West Virginia, United States, 25301|
|Principal Investigator:||Julio G. Davalos, MD||CAMC Medical Staff - with admitting privileges|
|Principal Investigator:||Frederick Martinez, M.D.||CAMC Medical Staff - with admitting privileges|